Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Lancaster

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The International Journal on Drug Policy|June 4, 2026
Presence, absence, and contingent engagement: mobilising care in the endgame of hepatitis C eliminationSophia E Schroeder, Tristan Duncan, Rebecca Winter, et al.
Drug and Alcohol Review|February 4, 2020
Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatmentKatinka van de Ven, Alison Ritter, Lynda Berends, et al.
Drug and Alcohol Review|March 2, 2011
Illicit drugs and the media: models of media effects for use in drug policy researchKari Lancaster, Caitlin E Hughes, Bridget Spicer, et al.
Drug and Alcohol Review|April 10, 2024
The 'missing' in the 'endgame' of hepatitis C elimination: A qualitative study in New South Wales, AustraliaCarla Treloar, Kari Lancaster, Tim Rhodes, et al.
Social Science & Medicine (1982)|January 26, 2024
Exhausting care: On the collateral realities of caring in the early days of the Covid-19 pandemicTim Rhodes, Maria Paula Ruiz Osorio, Adriana Maldonado Martinez, et al.
Harm Reduction Journal|July 7, 2022
A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigmaCarla Treloar, Elena Cama, Kari Lancaster, et al.
Sociology of Health & Illness|June 20, 2019
HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspectiveMartin Holt, Christy E Newman, Kari Lancaster, et al.
Australian and New Zealand Journal of Public Health|October 26, 2020
Australian news media reporting of methamphetamine: an analysis of print media 2014-2016Patrick Rawstorne, Rosslyn O'Connor, Amanda Cohn, et al.
The International Journal on Drug Policy|July 11, 2022
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depotCarla Treloar, Kari Lancaster, Sandra Gendera, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The International Journal on Drug Policy|June 4, 2026
Presence, absence, and contingent engagement: mobilising care in the endgame of hepatitis C eliminationSophia E Schroeder, Tristan Duncan, Rebecca Winter, et al.
Drug and Alcohol Review|February 4, 2020
Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatmentKatinka van de Ven, Alison Ritter, Lynda Berends, et al.
Drug and Alcohol Review|March 2, 2011
Illicit drugs and the media: models of media effects for use in drug policy researchKari Lancaster, Caitlin E Hughes, Bridget Spicer, et al.
Drug and Alcohol Review|April 10, 2024
The 'missing' in the 'endgame' of hepatitis C elimination: A qualitative study in New South Wales, AustraliaCarla Treloar, Kari Lancaster, Tim Rhodes, et al.
Social Science & Medicine (1982)|January 26, 2024
Exhausting care: On the collateral realities of caring in the early days of the Covid-19 pandemicTim Rhodes, Maria Paula Ruiz Osorio, Adriana Maldonado Martinez, et al.
Harm Reduction Journal|July 7, 2022
A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigmaCarla Treloar, Elena Cama, Kari Lancaster, et al.
Sociology of Health & Illness|June 20, 2019
HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspectiveMartin Holt, Christy E Newman, Kari Lancaster, et al.
Australian and New Zealand Journal of Public Health|October 26, 2020
Australian news media reporting of methamphetamine: an analysis of print media 2014-2016Patrick Rawstorne, Rosslyn O'Connor, Amanda Cohn, et al.
The International Journal on Drug Policy|July 11, 2022
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depotCarla Treloar, Kari Lancaster, Sandra Gendera, et al.
BMJ Open|August 2, 2020
Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB studyBriony Larance, Marianne Byrne, Nicholas Lintzeris, et al.
Pageof 8